CRB’s Ryan McDonough is featured in this month’s The Medicine Maker. His article, “NextGen Now: Delivering Tomorrow’s Facilities Today” discusses how cell and gene therapy products will successfully reach patients and deliver transformative cures, however the industry will need more facilities capable of manufacturing them.
Dave DiProspero will be presenting at the 2019 ISPE Europe Annual Conference on Wednesday, April 3 alongside Steve Marr, head of capital engineering/global manufacturing and supply for Takeda/Shire and Tony Crincoli, vice president of engineering for Glenmark Pharmaceuticals.
Celebrating 40 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization”. Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,500 global industry professionals and 620+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of no cost technical conference, exhibits, demonstrations, roundtables, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market.
Pilot plants represent a milestone in a drug’s commercial development, where drug sponsors first explore engineering, commercialization, clinical, regulatory, and process issues outside the relative safety of laboratory scale. And, as the test ground for a product’s ultimate manufacturability, pilot scale is where drug sponsors often return to de-bottleneck or to solve unanticipated production issues.
In today’s age of technology, manufacturers must guard themselves against cyberattacks. Automation and integration create more efficient facilities but can leave companies exposed if not properly secured.
The 2019 ISPE Aseptic Conference being held March 18-19 in North Bethesda, MD, focuses on the future of aseptic processing, including containment, multi-product facilities, and the increasing use of robotics. The attendees at the Aseptic Conference will be looking to not only learn about best practices in the industry, they also want to find out what are the latest and greatest in aseptic processing technologies.
Jim Contratto, a design and construction professional with 37 years of experience, has joined CRB’s Central region as the director of business development. Contratto has a wide range of knowledge in the construction industry, previously working in the areas of pre-construction, operations, design and business development. His understanding of complex construction projects in the life sciences and advanced technology industries bring an added level of expertise to CRB and CRB’s clients.
ISPE “Women in Pharma” provides women in the pharmaceutical industry a forum for connecting and collaborating on technical and career advancement topics and provide an opportunity for women to speak, deliver technical presentations, and contribute to panel discussions.